Wang J, Huang Z, Deng H, Zhao L, Deng H, Liu J
BMJ Open. 2022; 12(9):e059476.
PMID: 36104132
PMC: 9476114.
DOI: 10.1136/bmjopen-2021-059476.
Bus S, Broers M, Lucke I, Bunschoten C, van Lieverloo G, Adrichem M
J Neurol. 2021; 269(2):945-955.
PMID: 34173873
PMC: 8782785.
DOI: 10.1007/s00415-021-10677-5.
Loewenbruck K, Werner R, GuNTHER R, Dittrich M, Klingenberger R, Reichmann H
J Neurol. 2020; 268(4):1495-1507.
PMID: 33355881
PMC: 7990818.
DOI: 10.1007/s00415-020-10323-6.
Falzone Y, Campagnolo M, Bianco M, Dacci P, Martinelli D, Ruiz M
J Neurol. 2018; 265(12):2927-2933.
PMID: 30306264
PMC: 6244677.
DOI: 10.1007/s00415-018-9081-7.
Zhang A, MacIsaac R, Roberts L, Kamel J, Craig J, Busija L
BMJ Open. 2018; 8(3):e020804.
PMID: 29581208
PMC: 5875591.
DOI: 10.1136/bmjopen-2017-020804.
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes R, Mehndiratta M, Rajabally Y
Cochrane Database Syst Rev. 2017; 11:CD002062.
PMID: 29185258
PMC: 6747552.
DOI: 10.1002/14651858.CD002062.pub4.
The COMET Handbook: version 1.0.
Williamson P, Altman D, Bagley H, Barnes K, Blazeby J, Brookes S
Trials. 2017; 18(Suppl 3):280.
PMID: 28681707
PMC: 5499094.
DOI: 10.1186/s13063-017-1978-4.
Drug therapy for chronic idiopathic axonal polyneuropathy.
Warendorf J, Vrancken A, van Schaik I, Hughes R, Notermans N
Cochrane Database Syst Rev. 2017; 6:CD003456.
PMID: 28631805
PMC: 6481404.
DOI: 10.1002/14651858.CD003456.pub3.
Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial.
Merkies I, Lawo J, Edelman J, De Bleecker J, Sommer C, Robberecht W
J Peripher Nerv Syst. 2017; 22(2):149-152.
PMID: 28594116
PMC: 6084359.
DOI: 10.1111/jns.12204.
A review of patient and carer participation and the use of qualitative research in the development of core outcome sets.
Jones J, Jones L, Keeley T, Calvert M, Mathers J
PLoS One. 2017; 12(3):e0172937.
PMID: 28301485
PMC: 5354261.
DOI: 10.1371/journal.pone.0172937.
Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial.
de Greef B, Geerts M, Hoeijmakers J, Faber C, Merkies I
Trials. 2016; 17(1):330.
PMID: 27439408
PMC: 4955261.
DOI: 10.1186/s13063-016-1450-x.
Nerve ultrasound in the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis with predominant lower motor neuron disease (ALS/LMND).
Loewenbruck K, Liesenberg J, Dittrich M, Schafer J, Patzner B, Trausch B
J Neurol. 2015; 263(1):35-44.
PMID: 26477025
DOI: 10.1007/s00415-015-7927-9.
Treatment for IgG and IgA paraproteinaemic neuropathy.
Stork A, Lunn M, Nobile-Orazio E, Notermans N
Cochrane Database Syst Rev. 2015; (3):CD005376.
PMID: 25803231
PMC: 6781839.
DOI: 10.1002/14651858.CD005376.pub3.
Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach.
Berger M, Allen J
Muscle Nerve. 2014; 51(3):315-26.
PMID: 25418426
PMC: 4357394.
DOI: 10.1002/mus.24526.
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).
Leger J, De Bleecker J, Sommer C, Robberecht W, Saarela M, Kamienowski J
J Peripher Nerv Syst. 2013; 18(2):130-40.
PMID: 23781960
PMC: 3910165.
DOI: 10.1111/jns5.12017.
Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome.
Visser N, Vrancken A, van der Schouw Y, van den Berg L, Notermans N
Diabetes Care. 2012; 36(4):817-22.
PMID: 23204246
PMC: 3609524.
DOI: 10.2337/dc12-0469.
Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability.
Burns J, Ouvrier R, Estilow T, Shy R, Laura M, Pallant J
Ann Neurol. 2012; 71(5):642-52.
PMID: 22522479
PMC: 3335189.
DOI: 10.1002/ana.23572.
Counterpoint--the end point: less is more.
Fleming G
J Diabetes Sci Technol. 2011; 5(5):1290-3.
PMID: 22027331
PMC: 3208894.
DOI: 10.1177/193229681100500539.
Natural history of Charcot-Marie-Tooth 2: 2-year follow-up of muscle strength, walking ability and quality of life.
Padua L, Pareyson D, Aprile I, Cavallaro T, Quattrone D, Rizzuto N
Neurol Sci. 2009; 31(2):175-8.
PMID: 20016922
DOI: 10.1007/s10072-009-0202-z.
Relationship between clinical examination, quality of life, disability and depression in CMT patients: Italian multicenter study.
Padua L, Aprile I, Cavallaro T, Commodari I, Pareyson D, Quattrone A
Neurol Sci. 2008; 29(3):157-62.
PMID: 18612763
DOI: 10.1007/s10072-008-0928-z.
